News

Patients with spastic paraplegia type 15 develop movement disorders during adolescence that may ultimately require the use of a wheelchair. In the early stages of this rare hereditary disease the ...
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the presentation of new ...
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) peptide has garnered attention for its intriguing biological properties ...
Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum ...
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...
Many different cancer treatments work to directly target the tumor or the cells around it. The immediate goal is to mitigate ...
USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...
Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...